Thereby, increasing blood sugar disposal and improving glycemic control
However, subsequent meta-analyses and cohort studies found mixed or null results
When these receptors turn on in your intestines, they speed up how fast food moves through your colon, reducing water reabsorption and leading to loose or watery stools
The primary endpoint in most SURPASS studies was the reduction of glycated hemoglobin (HbA1c) , a laboratory marker reflecting average blood glucose levels over the previous two to three months
A 2019 meta-analysis in Annals of Internal Medicine (k=22 studies, N=8,992) found that DPP-modeled programs produced a mean weight loss of 3.9% at 12 months and reduced diabetes risk by 40% in real-world settings [6]
In my view, the future competition will not only depend on how strong the drug is, but also: Ease of use Patient comfort Supply and availability This is a big step forward in obesity treatment and shows how fast this field is growing